Use of the Accelerate Pheno System for Identification and Antimicrobial Susceptibility Testing of Pathogens in Positive Blood Cultures and Impact on Time to Results and Workflow

• Published in: Journal of clinical microbiology 2018-01, Vol.56 (1)
• Main Authors: Charnot-Katsikas, Angella, Tesic, Vera, Love, Nedra, Hill, Brandy, Bethel, Cindy, Boonlayangoor, Sue, Beavis, Kathleen G
• Format: Article
• Language: English
• Subjects: Anti-Infective Agents - pharmacology; Automation, Laboratory; Bacteria - drug effects; Bacteria - genetics; Bacteria - isolation & purification; Bacteriology; Blood - microbiology; Fungi - drug effects; Fungi - genetics; Fungi - isolation & purification; Hospitals, University; Humans; In Situ Hybridization, Fluorescence; Microbial Sensitivity Tests - methods; Microbiological Techniques - methods; Sensitivity and Specificity; Sepsis - diagnosis; Sepsis - microbiology; Time Factors; Workflow
• ISSN: 0095-1137; 1098-660X
• DOI: 10.1128/JCM.01166-17

The Accelerate Pheno system uses automated fluorescence hybridization technology with morphokinetic cellular analysis to provide rapid species identification (ID) and antimicrobial susceptibility testing (AST) results for the most commonly identified organisms in bloodstream infections. The objective was to evaluate the accuracy and workflow of bacterial and yeast ID and bacterial AST using the Accelerate Pheno system in the clinical microbiology laboratory. The consecutive fresh blood cultures received in the laboratory were analyzed by the Accelerate Pheno system within 0 to 8 h of growth detection. ID/AST performance, the average times to results, and workflow were compared to those of the routine standard of care. Of the 232 blood cultures evaluated (223 monomicrobial and 9 polymicrobial) comprising 241 organisms, the overall sensitivity and specificity for the identification of organisms were 95.6% and 99.5%, respectively. For antimicrobial susceptibility, the overall essential agreement was 95.1% and categorical agreement was 95.5% compared to routine methods. There was one very major error and 3 major errors. The time to identification and the time to susceptibility using the Accelerate Pheno system were decreased by 23.47 and 41.86 h, respectively, compared to those for the standard of care. The reduction in hands on time was 25.5 min per culture. The Accelerate Pheno system provides rapid and accurate ID/AST results for most of the organisms found routinely in blood cultures. It is easy to use, reduces hands on time for ID/AST of common blood pathogens, and enables clinically actionable results to be released much earlier than with the current standard of care.